Last reviewed · How we verify
Sulphadoxine-pyrimethamine with amodiaquine
Sulphadoxine-pyrimethamine with amodiaquine is a Small molecule drug developed by London School of Hygiene and Tropical Medicine. It is currently in Phase 2 development. Also known as: Supyra.
At a glance
| Generic name | Sulphadoxine-pyrimethamine with amodiaquine |
|---|---|
| Also known as | Supyra |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Perennial Malaria Chemoprevention in the Malaria Vaccine Era (PHASE4)
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi (PHASE4)
- Parasite Clearance and Protection from Infection (PCPI) in Cameroon (PHASE3)
- Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women (PHASE3)
- Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal (PHASE4)
- Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study (PHASE3)
- Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE) (PHASE4)
- Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sulphadoxine-pyrimethamine with amodiaquine CI brief — competitive landscape report
- Sulphadoxine-pyrimethamine with amodiaquine updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI
Frequently asked questions about Sulphadoxine-pyrimethamine with amodiaquine
What is Sulphadoxine-pyrimethamine with amodiaquine?
Sulphadoxine-pyrimethamine with amodiaquine is a Small molecule drug developed by London School of Hygiene and Tropical Medicine.
Who makes Sulphadoxine-pyrimethamine with amodiaquine?
Sulphadoxine-pyrimethamine with amodiaquine is developed by London School of Hygiene and Tropical Medicine (see full London School of Hygiene and Tropical Medicine pipeline at /company/london-school-of-hygiene-and-tropical-medicine).
Is Sulphadoxine-pyrimethamine with amodiaquine also known as anything else?
Sulphadoxine-pyrimethamine with amodiaquine is also known as Supyra.
What development phase is Sulphadoxine-pyrimethamine with amodiaquine in?
Sulphadoxine-pyrimethamine with amodiaquine is in Phase 2.
Related
- Manufacturer: London School of Hygiene and Tropical Medicine — full pipeline
- Also known as: Supyra
- Compare: Sulphadoxine-pyrimethamine with amodiaquine vs similar drugs
- Pricing: Sulphadoxine-pyrimethamine with amodiaquine cost, discount & access